Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30907077 | 0.97 | MAPT (0.35) | MAPT | |
| SCHEMBL20236060 | 0.92 | MAPT (0.33) | MAPT | |
| Boric Acid SCHEMBL20236055 | 0.92 | MAPT (0.33) | MAPT | |
| SCHEMBL27527153 | 0.82 | MAPT (0.36) | MAPTTSHRALOX15 | |
| SCHEMBL629330 | 0.80 | MAPT (0.35) | MAPT | |
| SCHEMBL27727629 | 0.78 | MAPT (0.34) | MAPTTSHR | |
| SCHEMBL8244794 | 0.75 | — | — | |
| SCHEMBL125434 | 0.75 | — | — | |
| SCHEMBL1537973 | 0.75 | — | — | |
| SCHEMBL20218688 | 0.74 | MAPT (0.32) | MAPTTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1219953-A | Fabric softening compound/composition | PROCTER & GAMBLE (US) | 1999-06-16 | — | — | CN | claimed |
| CN-1195369-A | Concentrated and stable fabric softening compositions | PROCTER & GAMBLE (US) | 1998-10-07 | — | — | CN | claimed |
| EP-3873504-B1 | ADIPOCYTE MEDIATED DELIVERY OF ANTICANCER THERAPEUTICS | UNIV NORTH CAROLINA STATE (US) | 2023-12-13 | — | — | EP | disclosed |
| CN-112955162-B | Adipocyte-mediated delivery of anticancer therapeutic agents | 北卡罗莱纳州立大学 | 2023-10-13 | — | — | CN | disclosed |
| US-20210369787-A1 | ADIPOCYTE MEDIATED DELIVERY OF ANTICANCER THERAPEUTICS | NORTH CAROLINA STATE UNIVERSITY | 2021-12-02 | — | — | US | disclosed |
| EP-3873504-A2 | ADIPOCYTE MEDIATED DELIVERY OF ANTICANCER THERAPEUTICS | North Carolina State University (US) | 2021-09-08 | — | — | EP | disclosed |
| CN-112955162-A | Adipocyte-mediated delivery of anticancer therapeutics | 北卡罗莱纳州立大学 | 2021-06-11 | — | — | CN | disclosed |
| EP-1963292-B1 | ORGANIC COMPOUNDS | NOVARTIS AG (CH) | 2012-02-22 | — | — | EP | disclosed |
| US-7700633-B2 | Organic compounds | NOVARTIS AG (CH) | 2010-04-20 | — | — | US | disclosed |
| US-20080262050-A1 | Organic Compounds | NOVARTIS AG (CH) | 2008-10-23 | — | — | US | disclosed |
| EP-1963292-A2 | ORGANIC COMPOUNDS | Novartis Pharma AG (CH) | 2008-09-03 | — | — | EP | disclosed |
| WO-2007067615-A2 | THIADIAZOLE DERIVATIVES AS ANTIDIABETIC AGENTS | NOVARTIS AG (CH) | 2007-06-14 | — | — | WO | disclosed |
| CN-1195369-A | Concentrated and stable fabric softening compositions | PROCTER & GAMBLE (US) | 1998-10-07 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080262050-A1 | Organic Compounds | PTPRS, PTPRO, PTPRC | MAPT 3222/4885TSHR 2240/4885ALOX15 250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.